FALK THOMAS J 4

What Happened
Thomas J. Falk, a director of AbbVie Inc. (ABBV), received an award of 1,118 restricted stock units (RSUs) on May 8, 2026. The RSUs were granted at a $0.00 per-share acquisition price (typical for awards) and will convert one-for-one into AbbVie common stock under the terms of the plan.

Key Details

• Transaction date: 2026-05-08 (reported on Form 4 filed 2026-05-12). Filing appears timely.
• Transaction type/code: Award/Grant (A).
• Amount: 1,118 RSUs; reported acquisition price $0.00 (award, not a market purchase).
• Shares owned after transaction: Not specified in this filing.
• Footnote F1: RSUs issued under the AbbVie Amended and Restated 2013 Incentive Stock Program; payable one-for-one in common stock on the earlier of the director’s separation from service, death, or a change in control.
• Footnote F2: Some securities are owned by a limited partnership jointly controlled by the reporting person and spouse; the reporting person disclaims beneficial ownership except to the extent of pecuniary interest.

Context
RSU grants to directors are common as part of board compensation and do not represent an open‑market buy or sell. These awards typically vest or convert to shares only on specified events (here: separation, death, or change in control), so there is no immediate share sale or cash transaction.